上機數控(603185.SH):子公司簽訂54.9億元單晶硅片長單銷售合同
格隆匯10月17日丨上機數控(603185.SH)公佈,公司下屬全資子公司弘元新材料(包頭)有限公司、弘元新材料(徐州)有限公司與一道新能源科技(衢州)有限公司、一道新能源科技(泰州)有限公司就“單晶硅片”的銷售簽訂合同。
對方自2023年1月至2024年12月總計向子公司採購單晶硅片8.25億片(上下浮動不超過20%),其中2023年1-12月採購3.45億片,2024年1-12月採購4.80億片。參照PVInfoLink最新公佈的價格測算,預計2023-2024年銷售金額為62.04億元(含税),不含税為54.90億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.